16 / 127
14
A interface vítreo-retiniana
AVM, TVM e BM
25 Perguntas e respostas
REFERÊNCIAS
1.
Sebag J. Anatomy and pathology of the vitreo-
retinal interface. Eye (Lond) 1992;6(Pt 6):541-52.
2.
De Smet MD, Gad Elkareem AM, Zwinder-
man AH. The vitreous, the retinal interface in
ocular health and disease. Ophthalmologica
2013;230(4):165-78.
3.
Sebag J. Age-related differences in the hu-
man vitreoretinal interface. Arch Ophthalmol
1991;109(7):966-71.
4.
Sebag J, Balazs EA. Morphology and ultrastruc-
ture of human vitreous fibers. Invest Ophthalmol
Vis Sci 1989;30(8):1867-71.
5.
Scott JE. The chemical morphology of the vitre-
ous. Eye (Lond) 1992;6 (Pt 6):553-5.
6.
Bishop PN. Structural macromolecules and su-
pramolecular organisation of the vitreous gel.
Prog Retin Eye Res 2000;19(3):323-44.
7.
Green WR SJ. Vitreoretinal Interface. In: Ryan
S (ed). Retina, Volume Three. 3th ed. St. Louis:
Mosby; 2001.
8.
Hogan MJ, Alvarado JA, Weddell JE. Histology
of the Human Eye: An Atlas and Textbookitle.
Philadelphia: Saunders W; 1971.
9.
Holekamp NM, Bai F, Shui Y-B, Almony A,
Beebe DC. Ischemic diabetic retinopathy may
protect against nuclear sclerotic cataract. Am J
Ophthalmol 2010;150(4):543-50.
10.
Holekamp NM, Shui YB, Beebe D. Lower in-
traocular oxygen tension in diabetic patients:
possible contribution to decreased incidence
of nuclear sclerotic cataract. Am J Ophthalmol
2006;141(6):1027-32.
11.
Repetto R, Siggers JH, Stocchino A. Mathemat-
ical model of flow in the vitreous humor induced
by saccadic eye rotations: effect of geometry.
Biomech Model Mechanobiol 2010;9(1):65-76.
12.
Stefánsson E. Ocular oxygenation and the treat-
ment of diabetic retinopathy. Surv Ophthalmol
2006;51(4):364-80.
13.
Xu J, Heys JJ, Barocas VH, Randolph TW.
Permeability and diffusion in vitreous humor:
implications for drug delivery. Pharm Res
2000;17(6):664-9.
14.
Shui YB, Holekamp NM, Kramer BC, Crowley
JR, Wilkins MA, Chu F et al. The gel state of the
vitreous and ascorbate-dependent oxygen con-
sumption: relationship to the etiology of nuclear
cataracts. Arch Ophthalmol 2009;127(4):475-
82.
15.
Stefansson E, Landers MB, Wolbarsht ML. Vit-
rectomy, lensectomy, and ocular oxygenation.
Retina 1982;2(3):159-66.
16.
Beebe DC, Holekamp NM, Siegfried C, Shui
YB. Vitreoretinal influences on lens function and
cataract. Philos Trans R Soc Lond B Biol Sci
2011;366(1568):1293-300.
17.
Akiba J. Prevalence of posterior vitreous de-
tachment in high myopia. Ophthalmology
1993;100(9):1384-8.
18.
Foos RY, Wheeler NC. Vitreoretinal juncture.
Synchysis senilis and posterior vitreous detach-
ment. Ophthalmology 1982;89(12):1502-12.
19.
Kishi S, Shimizu K. Posterior precortical vitreous
pocket. Arch Ophthalmol 1990;108(7):979-82.
20.
Spaide RF. Measurement of the posterior pre-
cortical vitreous pocket in fellow eyes with pos-
terior vitreous detachment and macular holes.
Retina 2003;23(4):481-5.
21.
Chuo JY, Lee TY, Hollands H, Morris AH, Reyes
RC, Rossiter JD et al. Risk factors for posterior
vitreous detachment: a case-control study. Am J
Ophthalmol 2006;142(6):931-7.
22.
Johnson MW. Posterior vitreous detachment:
evolution and complications of its early stages.
Am J Ophthalmol 2010;149(3):371-82.e1.
23.
Sebag J. Vitreous: the resplendent enigma. Br J
Ophthalmol 2009;93(8):989-91.
24.
Mayr-Sponer U, Waldstein SM, Kundi M, Rit-
ter M, Golbaz I, Heiling U et al. Influence of
the vitreomacular interface on outcomes of
ranibizumab therapy in neovascular age-re-
lated macular degeneration. Ophthalmology
2013;120(12):2620-9.
25.
Nomura Y, Ueta T, Iriyama A, Inoue Y, Obata R,
Tamaki Y et al. Vitreomacular interface in typical
exudative age-related macular degeneration and
polypoidal choroidal vasculopathy. Ophthalmol-
ogy 2011;118(5):853-9.
26.
Stefánsson E. Diabetic macular edema. Saudi J
Ophthalmol Soc. 2009;23(2):143-8.